Pluslife

Founded in 2017, Pluslife is advancing global healthcare with high-performance, cost-effective, and portable diagnostics that improve accessibility and health management for both humans and pets. Leveraging next-generation genetic technologies, we are building a reliable, easy-to-use testing ecosystem that redefines how people and animals access diagnostics.

Founded by top-tier national talents under China’s talent introduction program, Pluslife brings together a diverse team of professors, postdoctoral researchers, and professionals in diagnostics, protein engineering, and financial strategy, including CFA-certified individuals. Our facilities cover over 10,000 square meters, integrating offices, laboratories, and manufacturing sites.

The company has received multiple national honors, including Leading Entrepreneurial Talent and Team, Specialized and Innovative SME, High-Tech Enterprise, and the 2024 Healthcare CSR Model Enterprise.

Powered by proprietary RHAM technology, Pluslife has developed molecular POCT devices and test cards for major infectious diseases, respiratory and reproductive tract infections, and pathogens in companion animals. We have filed over 170 patent and certification applications, with more than 50 granted and 120 approved internationally. Our products are used across countries and regions worldwide.